(Q28361860)

English

Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination (English)

0 references

main subject

Staphylococcus aureus

1 reference

C M Perronne

1

0 references

R Malinverni

series ordinal

2

0 references

M P Glauser

series ordinal

3

0 references

language of work or name

English

0 references

publication date

April 1987

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

31

0 references

issue

4

0 references

page(s)

539-43

0 references

cites work

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

20 March 2017

Natural history of aortic valve endocarditis in rats

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

In vitro activity of coumermycin A1

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

Activity of coumermycin against clinical isolates of staphylococci

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

29 September 2017

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

2 June 2018

Antibacterial activity of coumermycin alone and in combination with other antibiotics

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

2 June 2018

STUDIES ON COUMERMYCIN, A NEW ANTIBIOTIC. I. PRODUCTION, ISOLATION AND CHARACTERIZATION OF COUMERMYCIN A1

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174774

retrieved

27 November 2018

Comparative imipenem treatment of Staphylococcus aureus endocarditis in the rat

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3606060

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic profile of coumermycin A

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3606060

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

PubMed publication ID

3606060

0 references

ResearchGate publication ID

19555991

0 references

(Q28361860)

Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)